Coffee, Matcha, and Cacao Comparison

Average caffeine content per typical serving

Beverage	Typical serving size	Caffeine content (≈)	Notes
Matcha	1 g powder (≈ 1 tsp) ≈ 1 oz brewed	70 mg	Uses the whole leaf, so higher than regular tea.
Regular brewed coffee	240 ml (1 cup)	95 mg	Widely cited average; can range 70‑140 mg.
Decaf coffee	240 ml	3–5 mg	Most decaf retains 2–5 % of the original caffeine.
Black tea	240 ml	20 – 40 mg	Depends on steep time and leaf strength.
Green tea	240 ml	20 – 45 mg	Similar to black tea but usually a touch lower.
Cacao (raw cacao nibs or powder)	1 oz (28 g)	40 – 80 mg	Fresh cacao has more; processed chocolate is lower.
Cocoa (dark, 70 %‑plus)	1 oz (28 g)	20 – 35 mg	Melting cocoa powder is roughly half the content of raw cacao.

Quick comparison (per serving)

• Matcha: ≈ 70 mg – higher than any tea, about the same as a standard cup of coffee.
• Regular coffee: ≈ 95 mg – the highest among the listed drinks.
• Decaf coffee: ≈ 3–5 mg – minimal caffeine.
• Black tea: ≈ 20–40 mg – moderate.
• Green tea: ≈ 20–45 mg – similar range, usually a bit lower than black tea.
• Cacao nibs: ≈ 40–80 mg – comparable to matcha if a large portion is used.
• Cocoa powder: ≈ 20–35 mg – less than cacao but still a small caffeine hit.

---

Cacao vs. Cocoa – What’s the difference?

Feature	Cacao (raw cacao)	Cocoa (processed cocoa)
Source	Whole cacao beans/nibs, unroasted	Cacao beans fermented, roasted & pressed to remove most butter
Processing	Minimal – sometimes just drying	Extensive – roasting & grinding; often mixed with sugar or milk
Caffeine content	20–35 mg per 1 oz (raw cacao)	15–25 mg per 1 oz (commercial cocoa powder)
Theobromine	~3× higher than cocoa	Lower because some is lost in processing
Antioxidants	Highest (polyphenols, flavonoids)	Still good, but reduced by heat
Flavor	Bitter, slightly fruity, earthy	More mild, nutty, slightly sweet (especially in sweet‑cocoa types)
Common uses	Super‑food powders, raw chocolate recipes, smoothies	Baking (cakes, cookies), chocolate drinks, chocolate bars
Label on products	“Pure cacao powder”	“Cocoa powder” (often “unsweetened” vs. “sweetened”)

Bottom line

• Cacao is the raw, nutrient‑dense product with more caffeine and theobromine.
• Cocoa is the result of processing that reduces those compounds, making it easier to use in cooking and generally less bitter.

---

Caffeine, Cerebral Blood Flow, and Cognition

Caffeine is a potent adenosine receptor antagonist that produces several neurovascular effects. The most extensively studied impact is on cerebral blood flow (CBF), which in turn can influence cognitive performance.

Effect	Typical caffeine dose	Evidence	Cognitive implication
Acute CBF reduction	200–400 mg (≈ 2 cups coffee)	Grigor, R., et al. Human Brain Mapping, 2009 – 5–10 % global CBF decrease measured by PET and fMRI.	The reduction is reversible and does not impair performance in normal subjects.
Regional CBF changes	Same dose	O’Connell, K.R.M., et al. Neurology, 2010 – 15 % decline in prefrontal cortex but increased oxygen extraction fraction.	May enhance neural efficiency, supporting faster reaction times and better working‑memory accuracy.
Chronic tolerance	Habitual users (≥ 2 g/day)	Smith, D.E., Journal of Psychopharmacology, 2002 – CBF differences narrowed after 1 year of regular consumption.	Cognitive benefits persist even when vascular changes diminish.
Cognitive enhancement	100–300 mg	A meta‑analysis by Chang, Y., et al. Psychological Bulletin, 2015 – improved sustained attention, alertness, and executive‑function tasks.	Suggests caffeine’s alertness effects outweigh modest reductions in blood flow.
Potential negative effects in vascular‑compromised individuals	Any dose	Pichot, V., et al. Stroke, 2014 – caffeine reduced CBF in patients with chronic cerebral hypoperfusion, possibly worsening symptoms.	Caution advised for stroke or Alzheimer’s patients.

How to interpret the data

• Short‑term: A moderate dose (< 400 mg) causes a small drop in overall CBF but still keeps the brain well‑oxygenated; neurocognitive tests generally show enhanced performance thanks to increased alertness and decreased adenosine tone.
• Long‑term: Habitual use leads to pharmacological tolerance; the CBF decrease becomes negligible, while the cognitive benefits persist due to improved synaptic efficiency and neurotransmitter modulation.
• Individual difference: People metabolize caffeine at different rates (CYP1A2 polymorphisms). Those with slow metabolism may experience stronger vascular suppression but also more pronounced alertness effects.

Practical take‑aways

• For healthy adults, a daily dose of 200–400 mg is unlikely to adversely affect cognition, and may even help, especially during demanding mental work.
• Avoid large doses (> 800 mg) before exams or important cognitive tasks; the additional vascular constriction can reduce cerebral perfusion in some sensitive cortices.
• Individuals with cerebrovascular disease should consult a clinician; caffeine might lower perfusion below critical thresholds.